[go: up one dir, main page]

DE60318384D1 - Nicht-hygroskopische pharmazeutische Zusammensetzungen die nicht hydratisierte Quinolon-Carbonsäure enthalten - Google Patents

Nicht-hygroskopische pharmazeutische Zusammensetzungen die nicht hydratisierte Quinolon-Carbonsäure enthalten

Info

Publication number
DE60318384D1
DE60318384D1 DE60318384T DE60318384T DE60318384D1 DE 60318384 D1 DE60318384 D1 DE 60318384D1 DE 60318384 T DE60318384 T DE 60318384T DE 60318384 T DE60318384 T DE 60318384T DE 60318384 D1 DE60318384 D1 DE 60318384D1
Authority
DE
Germany
Prior art keywords
carboxylic acid
hydrated
pharmaceutical compositions
compositions containing
quinolone carboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60318384T
Other languages
English (en)
Other versions
DE60318384T2 (de
Inventor
Adnan Dr Badwan
Lina Najati Nabulsi
Mahmoud M Omari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jordanian Pharmaceutical Manufacturing Co
Original Assignee
Jordanian Pharmaceutical Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Manufacturing Co filed Critical Jordanian Pharmaceutical Manufacturing Co
Application granted granted Critical
Publication of DE60318384D1 publication Critical patent/DE60318384D1/de
Publication of DE60318384T2 publication Critical patent/DE60318384T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60318384T 2003-03-19 2003-03-19 Nicht-hygroskopische pharmazeutische Zusammensetzungen die nicht hydratisierte Quinolon-Carbonsäuren enthalten Expired - Fee Related DE60318384T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03006160A EP1459739B1 (de) 2003-03-19 2003-03-19 Nicht-hygroskopische pharmazeutische Zusammensetzungen die nicht hydratisierte Quinolon-Carbonsäure enthalten

Publications (2)

Publication Number Publication Date
DE60318384D1 true DE60318384D1 (de) 2008-02-14
DE60318384T2 DE60318384T2 (de) 2009-02-19

Family

ID=32798836

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60318384T Expired - Fee Related DE60318384T2 (de) 2003-03-19 2003-03-19 Nicht-hygroskopische pharmazeutische Zusammensetzungen die nicht hydratisierte Quinolon-Carbonsäuren enthalten

Country Status (7)

Country Link
US (1) US20040224014A1 (de)
EP (1) EP1459739B1 (de)
JP (1) JP2004339198A (de)
AT (1) ATE382338T1 (de)
DE (1) DE60318384T2 (de)
DK (1) DK1459739T3 (de)
ES (1) ES2297067T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006110815A1 (en) * 2005-04-11 2006-10-19 Abbott Laboratories Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
EP1901749B1 (de) * 2005-05-18 2016-08-03 Raptor Pharmaceuticals Inc. Aerosolisierte fluorochinolone und ihre verwendungen
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PL2101733T3 (pl) * 2006-12-13 2013-02-28 Hoffmann La Roche Preparat w postaci proszku walgancyklowiru
CN102202649A (zh) 2008-10-07 2011-09-28 Mpex医药有限公司 用于改进的药物动力学的氟喹诺酮气雾剂制剂
PL2346509T3 (pl) 2008-10-07 2021-03-08 Horizon Orphan Llc Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc
KR20120100904A (ko) 2009-09-04 2012-09-12 엠펙스 파마슈티컬즈, 인코포레이티드 낭포성 섬유증을 치료하기 위한 에어로졸화된 레보플록사신의 용도
WO2013081044A1 (ja) * 2011-11-30 2013-06-06 富山化学工業株式会社 1-シクロプロピル-8-(ジフルオロメトキシ)-7-[(1r)-1-メチル-2,3-ジヒドロ-1h-イソインドール-5-イル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸のメタンスルホン酸塩水和物含有錠剤
CA2910112C (en) 2013-04-25 2021-02-16 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
EP2990039A4 (de) 2013-04-25 2017-02-22 Kyorin Pharmaceutical Co., Ltd. Feste pharmazeutische zusammensetzung
EP3210607A4 (de) 2014-10-23 2018-06-06 Kyorin Pharmaceutical Co., Ltd. Feste pharmazeutische zusammensetzung
CN106310229A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种马昔瑞林薄膜衣片及其制备方法
CN107115312A (zh) * 2017-05-17 2017-09-01 湖南新汇制药股份有限公司 一种诺氟沙星片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
IT1319664B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di antibatterici chinolonici con polimeri polisaccaridicinaturali.

Also Published As

Publication number Publication date
JP2004339198A (ja) 2004-12-02
ATE382338T1 (de) 2008-01-15
EP1459739B1 (de) 2008-01-02
US20040224014A1 (en) 2004-11-11
EP1459739A1 (de) 2004-09-22
ES2297067T3 (es) 2008-05-01
DK1459739T3 (da) 2008-05-19
DE60318384T2 (de) 2009-02-19

Similar Documents

Publication Publication Date Title
DE60318384D1 (de) Nicht-hygroskopische pharmazeutische Zusammensetzungen die nicht hydratisierte Quinolon-Carbonsäure enthalten
ATE550038T1 (de) Orale darreichungsform enthaltend einen pde-4 hemmer als wirkstoff und polyvinylpyrrolidone als hilfstoff
ATE376423T1 (de) Gelierende wässrige pharmazeutische zusammensetzungen
NO20003196L (no) Umiddelbart opplösende doseringsformulering
PT785775E (pt) Formulacoes opioides extrudidas por fusao administraveis oralmente
DK2311459T3 (da) Manipulationsmodstandsdygtige orale, farmaceutiske doseringsformer indeholdende et opioidanalgetikum
NO20034627L (no) Oralt avleverbart farmasöytisk preparat innbefattende en aktiv forbindelsemed en aminosulfonylgruppe (cox-2 inhibitor) en polyetylenglykolog et friradikal-fjernende antioksidasjonsmiddel
HUP0303810A3 (en) Carboxylic acid derivative and salt thereof and pharmaceutical compositions containing them
DE50212546D1 (de) Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung
BR0213477A (pt) Grânulos orais e composição farmacêutica escoável e dispersìvel
LT2001119A (en) Pharmaceutical formulations comprising intranasal morphine and use thereof
BG106158A (en) New use of compounds as antibacterial agents
ATE383859T1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
NO20041383L (no) Flashsmelte oral doseringsformulering
DE60025503D1 (de) Pharmazeutische Zusammensetzungen, die Faropenem Natrium und eine Diamineacetat Verbindung zur Verbesserung der Magen-Darm Trakt Absorption enthalten
DK1643976T3 (da) Farmaceutisk formulering omfattende levothyroxinnatrium
ATE285779T1 (de) Ciclesonidhaltige arzneizusammensetzung zur verabreichung auf die schleimhäute
IL174336A0 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
IT1303753B1 (it) Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici.
JO2567B1 (en) Non-water-absorbing pharmaceutical formula containing non-hydrated carboxylic quinoline acids
JPH0729884B2 (ja) 粘稠状殺菌剤組成物
ATE530172T1 (de) Pharmazeutische formulierungen mit clopidogrel
ATE429227T1 (de) Pharmazeutische zusammensetzung für die orale verabreichung eines pyrazol-3-carbonsäurederivats
ITTO20020672A1 (it) Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
RU2001105595A (ru) Ветеринарный препарат

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee